Jean-Christophe Maiza

Jean-Christophe Maiza

Auto-generated profile, based on publicly available information

Jean-Christophe Maiza

Department of Endocrinology, Diabetes, and Nutrition, GHSR, Centre Hospitalo-Universitaire de la Réunion , 97448 Saint-Pierre, La Réunion , France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2024 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
BCBenjamin Chevalier
Benjamin Chevalier
LCLucie Coppin
Lucie Coppin
PRPauline Romanet
Pauline Romanet
TCThomas Cuny
Thomas Cuny
JMJean-Christophe Maïza
Jean-Christophe Maïza
MOMarie Françoise Odou
Marie Françoise Odou
Context Germline CDKN1B variants predispose patients to multiple endocrine neoplasia type 4 (MEN4), a rare MEN1-like syndrome, with <100 reported cases since its discovery in 2006. Although CDKN1B mutations are frequently suggested to explain cases of genetically-negative MEN1, the prevalence and phenotype of MEN4 patients is poorly known, and genetic counseling is unclear. Objective To evaluate the prevalence of MEN4 in MEN1-suspected patients and characterize the phenotype of MEN4 patients. Design Retrospective observational nationwide study. Narrative review of literature and variant class reassessment. Patients We included all adult patients with class 3/4/5 CDKN1B variants identified by the laboratories from the French TENGEN network between 2015 and 2022 through germline genetic testing for MEN1 suspicion. After class reassessment, we compared the phenotype of symptomatic patients with class 4/5 CDKN1B variants, i.e. with genetically-confirmed MEN4 diagnosis, in our series and in literature with 66 matched MEN1 patients from the UMD-MEN1 database. Results From 5600 MEN1-suspected patients analyzed, four patients with class 4/5 CDKN1B variant were found (0.07%). They presented with multiple duodenal NET, PHPT and adrenal nodule, isolated PHPT, PHPT and pNET. We listed 29 patients with CDKN1B class 4/5 variants from literature. Compared to matched MEN1 patients, MEN4 patients presented lower NET incidence and older age at PHPT diagnosis. Conclusion The prevalence of MEN4 is low. PHPT and PA represent the main associated lesions, NETs are rare. Our results suggest a milder and later phenotype than in MEN1. Our observations will help to improve genetic counseling and management of MEN4 families.

15 November 2022 in Diabetes & Metabolism
Verified
Journal Article
Closed access
GTGuillaume Treiber
Guillaume Treiber
AGAlice Guilleux
Alice Guilleux
KHKevin Huynh
Kevin Huynh
OBOriane Bonfanti
Oriane Bonfanti
AFAnia Flaus–Furmaniuk
Ania Flaus–Furmaniuk
ENEstelle Nobécourt
Estelle Nobécourt

19 October 2012 in Pituitary
Verified
Journal Article
Closed access
PDF file
JMJean-Christophe Maiza
Jean-Christophe Maiza
PZPatricia Zunic
Patricia Zunic
CRCedric Revel
Cedric Revel
SSStephane Schneebeli
Stephane Schneebeli

1 March 2023 in medRxiv
Verified
Preprint
Open access
PDF file
AIAzizah Issop
Azizah Issop
ABAntoine Bertolotti
Antoine Bertolotti
YDYves-Marie Diarra
Yves-Marie Diarra
JMJean-Christophe Maïza
Jean-Christophe Maïza
ÉJÉric Jarlet
Éric Jarlet
PGPatrick Gérardin
Patrick Gérardin
Aim Diabetes mellitus is associated with both the risks of severe dengue and dengue-related deaths, however the factors characterizing dengue in the diabetic patient are ill-recognized. The objective of this hospital-based cohort study was to identify the factors characterizing dengue and those able to predict dengue severity in the diabetic patient. Methods We retrospectively analysed demographic, clinical and biological parameters at admission in the cohort of patients who consulted at the university hospital between January and June 2019 with confirmed dengue. Bivariate and multivariate analyses were conducted. Results Of 936 patients, 184 patients (20%) were diabetic. One hundred and eighty-eight patients (20%) developed severe dengue according to the WHO 2009 definition. Diabetic patients were older and had more comorbidities than non-diabetics. In an age-adjusted logistic regression model, loss of appetite, altered mental status, high neutrophil to platelet ratios (>14.7), low haematocrit (≤ 38%), upper-range serum creatinine (>100 μmol/l) and high urea to creatinine ratio (>50) were indicative of dengue in the diabetic patients. In a modified Poisson regression model, four key independent variables were predictive of severe dengue in the diabetic patient: presence of diabetes complications, non-severe bleeding, altered mental status and cough. Among diabetes complications, diabetic retinopathy, and neuropathy but not diabetic nephropathy nor diabetic foot were predictive of severe dengue. Conclusion At hospital first presentation, dengue in the diabetic patient is characterized by deteriorations in appetite, mental and renal functioning, while severe dengue can be predicted by presence of diabetes complication, dengue-related non-severe haemorrhages, cough, and dengue-related encephalopathy.